Items where Author is "Rushbrook, Simon"

Group by: Item Type | Status | No Grouping
Number of items: 7.

Phillips, Sarah, Watt, Rachel, Atkinson, Thomas, Rajan, Shelina, Hayhoe, Antonietta, Savva, George M., Hornberger, Michael ORCID: https://orcid.org/0000-0002-2214-3788, Burton, Ben J. L., Saada, Janak, Cambell-Kelly, Melissa, Rushbrook, Simon and Carding, Simon R. (2022) A protocol paper for the MOTION Study—A longitudinal study in a cohort aged 60 years and older to obtain mechanistic knowledge of the role of the gut microbiome during normal healthy ageing in order to develop strategies that will improve lifelong health and wellbeing. PLoS One, 17 (11). ISSN 1932-6203

Isaacs-Ten, Anna, Echeandia, Marta, Moreno-Gonzalez, Mar, Brion, Arlaine, Goldson, Andrew, Philo, Mark, Patterson, Angela M., Parker, Aimee, Galduroz, Mikel, Baker, David, Rushbrook, Simon M., Hildebrand, Falk and Beraza, Naiara (2020) Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice. Hepatology, 72 (6). pp. 2090-2108. ISSN 0270-9139

Goode, Elizabeth C., Hirschfield, Gideon M. and Rushbrook, Simon M. (2020) A novel prognostic model for transplant-free survival in primary sclerosing cholangitis REPLY. Hepatology, 71 (1). pp. 399-400. ISSN 0270-9139

Patel, Meha, Watson, Alastair J. M. ORCID: https://orcid.org/0000-0003-3326-0426 and Rushbrook, Simon (2019) A mechanistic insight into the role of gut microbiota in the pathogenesis of primary sclerosing cholangitis. Gastroenterology, 157 (6). pp. 1686-1688. ISSN 0016-5085

Trauner, Michael, Gulamhusein, Aliya, Hameed, Bilal, Caldwell, Stephen, Shiffman, Mitchell L., Landis, Charles, Eksteen, Bertus, Agarwal, Kosh, Muir, Andrew, Rushbrook, Simon, Lu, Xiaomin, Xu, Jun, Chuang, Jen-Chieh, Billin, Andrew N., Li, Georgia, Chung, Chuhan, Subramanian, G. Mani, Myers, Robert P., Bowlus, Christopher L. and Kowdley, Kris V. (2019) The nonsteroidal Farnesoid X receptor agonist Cilofexor (GS-9674) improves markers of Cholestasis and liver injury in patients with primary sclerosing cholangitis. Hepatology, 70 (3). pp. 788-801. ISSN 0270-9139

Blokker, Britt A, Maijo, Monica, Echeandia, Marta, Galduroz, Mikel, Patterson, Angela M, Ten, Anna, Philo, Mark, Schungel, Rebecca, Gutierrez-de Juan, Virginia, Halilbasic, Emina, Fuchs, Claudia, Le Gall, Gwenaelle ORCID: https://orcid.org/0000-0002-1379-2196, Milkiewicz, Malgorzata, Milkiewicz, Piotr, Banales, Jesus M, Rushbrook, Simon M, Mato, José M, Trauner, Michael, Müller, Michael ORCID: https://orcid.org/0000-0002-5930-9905, Martínez-Chantar, María Luz, Varela-Rey, Marta and Beraza, Naiara (2019) Fine-tuning of SIRT1 expression is essential to protect the liver from cholestatic liver disease. Hepatology, 69 (2). pp. 699-716. ISSN 0270-9139

Vauzour, David ORCID: https://orcid.org/0000-0001-5952-8756, Rodriguez Ramiro, Ildefonso, Rushbrook, Simon, Ipharraguerre, Ignacio R., Bevan, Damon, Davies, Susan, Tejera, Noemi, Mena, Pedro, de Pascual-Teresa, Sonia, Del Rio, Daniele, Gavrilovic, Jelena ORCID: https://orcid.org/0000-0002-5312-1784 and Minihane, Anne-Marie ORCID: https://orcid.org/0000-0001-9042-4226 (2018) N-3 fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1864 (1). pp. 69-78. ISSN 0925-4439

This list was generated on Fri Mar 29 01:28:04 2024 UTC.